VERU INC. Proceeds from Long-term Lines of Credit
VERU INC. (VERU) reported Proceeds from Long-term Lines of Credit of $836.78 thousand for the 6-month period ending 2020-03-31, per its 10-Q filed 2020-05-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLongTermLinesOfCredit · last filed 2020-05-13
- VERU INC. proceeds from long-term lines of credit for the quarter ending 2020-03-31 was $0.00.
- VERU INC. proceeds from long-term lines of credit for the quarter ending 2019-12-31 was $836.78K.
- VERU INC. proceeds from long-term lines of credit for the quarter ending 2018-09-30 was $0.00.
- VERU INC. proceeds from long-term lines of credit for the quarter ending 2018-06-30 was $0.00.
- VERU INC. proceeds from long-term lines of credit for fiscal 2018 was $10.00M.
| Period end | Proceeds from Long-term Lines of Credit 3 month | Proceeds from Long-term Lines of Credit 6 month | Proceeds from Long-term Lines of Credit 9 month | Proceeds from Long-term Lines of Credit 12 month |
|---|---|---|---|---|
| 2020-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-13 | $836.78K 10-Q · filed 2020-05-13 | ||
| 2019-12-31 | $836.78K 10-Q · filed 2020-02-12 | |||
| 2018-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-12 | $0.00 derived: sum of 2 quarters · filed 2019-12-12 | $10.00M 10-K · filed 2019-12-12 | |
| 2018-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-08 | $10.00M 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $10.00M 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |